Browse by Person (creator, editor, contributor, etc.)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 13.

Article

Bullock, R.A. and Bergman, H. and Touchon, J. and Gambina, G. and He, Y. and Nagel, J. and Lane, R. (2006) Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Current Medical Research and Opinion, 22 (3). pp. 483-494. ISSN 0300-7995. (The full text of this publication is not available from this repository)

Blesa, R. and Bullock, R.A. and He, Y. and Bergman, H. and Gambina, G. and Mian, S. and Rapatz, G. and Nagel, J. and Lane, R. (2006) Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Pharmacogenet and Genomics, 16 (11). pp. 771-774. ISSN 1744-6872. (The full text of this publication is not available from this repository)

Touchon, J. and Bergman, H. and Bullock, R.A. and Rapatz, G. and Nagel, J. and Lane, R. (2006) Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. Current Medical Research and Opinion, 22 (1). pp. 49-60. ISSN 0300-7995. (The full text of this publication is not available from this repository)

Bullock, R.A. and Touchon, J. and Bergman, H. and Gambina, G. and He, Y. and Rapatz, G. and Nagel, J. and Lane, R. (2005) Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. Current Medical Research and Opinion, 21 (8). pp. 1317-1327. ISSN 0300-7995. (The full text of this publication is not available from this repository)

Bayer, A. and Bullock, R.A. and Jones, R. and Wilkinson, D. and Donaghue, S. (2005) Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology, 64 (1). pp. 94-101. ISSN 0340-5354. (The full text of this publication is not available from this repository)

Robert, P.H. and Verhey, F.R. and Byrne, E.J. and Hurt, C. and De Deyn, P.P. and Nobili, F. and Riello, R. and Rodriguez, G. and Frisoni, G.B. and Tsolaki, M. and Kyriazopoulou, N. and Bullock, R.A. and Burns, A. and Vellas, B. (2005) Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry, 20 (7). pp. 490-496. ISSN 0924-9338. (The full text of this publication is not available from this repository)

Kalbe, E. and Kessler, J. and Calabrese, P. and Smith, R. and Passmore, A.P. and Brand, M. and Bullock, R.A. (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal of Geriatric Psychiatry, 19 (2). pp. 136-143. ISSN 0885-6230. (The full text of this publication is not available from this repository)

Voss, S.E. and Bullock, R.A. (2004) Executive function: The core feature of dementia? Dementia and Geriatric Cognitive Disorders, 18 (2). pp. 207-216. ISSN 1420-8008. (The full text of this publication is not available from this repository)

Bullock, R.A. and Erkinjuntti, T. and Lilienfeld, S. (2004) Management of patients with Alzheimer's disease plus cerebrovascular disease: 12 month treatment with galantamine. Dementia and Geriatric Cognitive Disorders, 17 (1-2). pp. 29-34. ISSN 1420-8008. (The full text of this publication is not available from this repository)

Ward, A. and Caro, J.J. and Getsios, D. and Ishak, K. and O'Brien, J. and Bullock, R.A. (2003) Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK. International Journal of Geriatric Psychiatry, 18 (8). pp. 740-747. ISSN 0885-6230. (The full text of this publication is not available from this repository)

Erkinjuntti, T. and Kurz, A. and Small, G. and Bullock, R.A. and Lilienfeld, S. and Damaraju, C.V. (2003) An open-label extension trail of galantamine in patients with probable vascular dementia and mixed dementia. Clinical Therapeutics, 25 (6). pp. 1765-2336. ISSN 0149 2918. (The full text of this publication is not available from this repository)

Erkinjuntti, T. and Kurz, A. and Small, G. and Bullock, R.A. and Lilienfeld, S. and Rao, C. and Damaraju, V. (2003) The 12-Month Effects of Galantamine in Probable Vascular Dementia and Mixed Dementia. Clinical Therapeutics, 5 (6). pp. 1765-1782. ISSN 0149-2918. (The full text of this publication is not available from this repository)

Erkinjuntti, T. and Kurz, A. and Gauthier, S. and Bullock, R.A. and Lilienfeld, S. and Rao, C. and Damaraju, V. (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet, 359 (9314). pp. 1283-1290. ISSN 0140-6736. (The full text of this publication is not available from this repository)

This list was generated on Thu Apr 17 21:43:15 2014 BST.